Media coverage
2
Media coverage
Title ‘BTK Inhibitor Brukinsa is a safe option in CLL treatment’ Media name/outlet Korea Biomedical Review Date 1/07/24 URL ct.moreover.com/?a=54187224684&p=1gw&v=1&x=C-PxnLsoe6aTdsxGdYSEhA Persons Young Sup Woo Title Hospital ‘BTK Inhibitor Brukinsa is a safe option in CLL treatment’ The diagnosis of leukemia still strikes fear in many people. Scenes of leukemia patients in movies and TV shows conjure up images of intense chemotherapy and hair loss. However, de... Kim Media name/outlet Korea Biomedical Review Date 1/07/24 URL ct.moreover.com/?a=54187566728&p=1gw&v=1&x=qoufNUZp_povQzpQK5b2qA Persons Young Sup Woo